| 标题 |
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction–associated steatohepatitis 综合筛查确定GPR31是代谢功能障碍相关脂肪性肝炎的关键驱动因素和可药物靶标
|
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Investigation 作者:Xiao-Jing Zhang; Jiajun Fu; Xu Cheng; Hong Shen; Hailong Yang; et al 出版日期:2025 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)